PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway

References

• Liu H, Wang Y, Zhang Y, Song Q, Di C, Chen G, et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 1999; 254:203 - 10; http://dx.doi.org/10.1006/bbrc.1998.9893; PMID: 9920759
   PubMed Web of Science ®Google Scholar
• Chen Y, Sun R, Han W, Zhang Y, Song Q, Di C, et al. Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis?. FEBS Lett 2001; 509:191 - 6; http://dx.doi.org/10.1016/S0014-5793(01)03062-9; PMID: 11741587
   PubMed Web of Science ®Google Scholar
• Zhang YM, Liu HT, Song QS, Ma DL. The apoptosis-accelerating effect of human recombinant TFAR19 protein on leukemia HL-60 cells. J Clin Immunol 2000; 16:8 - 11
   Google Scholar
• Rui M, Chen Y, Zhang Y, Ma D. Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis. Life Sci 2002; 71:1771 - 8; http://dx.doi.org/10.1016/S0024-3205(02)01943-4; PMID: 12151055
   PubMed Web of Science ®Google Scholar
• Chen LN, Wang Y, Ma DL, Chen YY. Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 2006; 11:101 - 11; http://dx.doi.org/10.1007/s10495-005-3134-y; PMID: 16374546
   PubMed Web of Science ®Google Scholar
• Salvi M, Xu D, Chen Y, Cabrelle A, Sarno S, Pinna LA. Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells. Biochem Biophys Res Commun 2009; 387:606 - 10; http://dx.doi.org/10.1016/j.bbrc.2009.07.067; PMID: 19616514
   PubMed Web of Science ®Google Scholar
• Xu L, Chen Y, Song Q, Xu D, Wang Y, Ma D. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 2009; 11:345 - 54; PMID: 19308289
   PubMed Web of Science ®Google Scholar
• Yang YH, Zhao M, Li WM, Lu YY, Chen YY, Kang B, et al. Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 2006; 11:993 - 1001; http://dx.doi.org/10.1007/s10495-006-6714-6; PMID: 16547588
   PubMed Web of Science ®Google Scholar
• Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A 2001; 98:15089 - 94; http://dx.doi.org/10.1073/pnas.241522398; PMID: 11752456
   PubMed Web of Science ®Google Scholar
• Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001; 344:539 - 48; http://dx.doi.org/10.1056/NEJM200102223440801; PMID: 11207349
   PubMed Web of Science ®Google Scholar
• Ruan GR, Qin YZ, Chen SS, Li JL, Ma X, Chang Y, et al. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 2006; 30:1159 - 65; http://dx.doi.org/10.1016/j.leukres.2005.12.028; PMID: 16507320
   PubMed Web of Science ®Google Scholar
• Jiang TB, Li X, Zhou J, Zhou Y, Yuan H, Xiang H, et al. [Expression of PDCD5 in multiple myeloma and its relation with BCL-2]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008; 33:814 - 20; PMID: 18812660
   PubMedGoogle Scholar
• Zhang X, Wang X, Song X, Wei Z, Zhou C, Zhu F, et al. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas. Oncol Rep 2011; 25:353 - 8; http://dx.doi.org/10.3892/or.2010.1103; PMID: 21165576
   PubMed Web of Science ®Google Scholar
• Chen C, Zhou H, Xu L, Liu X, Liu Z, Ma D, et al. Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma. Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma. J Surg Oncol 2010; 102:838 - 43; http://dx.doi.org/10.1002/jso.21730; PMID: 20872801
   PubMed Web of Science ®Google Scholar
• Ma X, Ruan G, Wang Y, Li Q, Zhu P, Qin YZ, et al. Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5′ regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res 2005; 11:8592 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-05-0039; PMID: 16361542
   PubMed Web of Science ®Google Scholar
• Gu L, Jiang Y, Wang Y, Yao W, Sun D, Ka W, et al. TFAR19 gene changes the biophysical properties of murine erythroleukemia cells. Cell Biochem Biophys 2005; 43:355 - 63; http://dx.doi.org/10.1385/CBB:43:3:355; PMID: 16247177
   PubMed Web of Science ®Google Scholar
• Spinola M, Meyer P, Kammerer S, Falvella FS, Boettger MB, Hoyal CR, et al. Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J Clin Oncol 2006; 24:1672 - 8; http://dx.doi.org/10.1200/JCO.2005.04.4339; PMID: 16549820
   PubMed Web of Science ®Google Scholar
• Shi L, Song Q, Zhang Y, Lou Y, Wang Y, Tian L, et al. Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells. Biochem Biophys Res Commun 2010; 396:224 - 30; http://dx.doi.org/10.1016/j.bbrc.2010.04.068; PMID: 20398626
   PubMed Web of Science ®Google Scholar
• Li H, Wang Q, Gao F, Zhu F, Wang X, Zhou C, et al. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol Rep 2008; 20:573 - 9; PMID: 18695908
   PubMed Web of Science ®Google Scholar
• Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002; 359:1011 - 8; http://dx.doi.org/10.1016/S0140-6736(02)08091-1; PMID: 11937180
   PubMed Web of Science ®Google Scholar
• Yin A, Jiang Y, Zhang X, Zhao J, Luo H.. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. Eur J Pharmacol 2010; 649:120 - 126
   PubMed Web of Science ®Google Scholar
• Chen C, Zhou H, Xu L, Xu D, Wang Y, Zhang Y, et al. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis 2010; 15:805 - 13; http://dx.doi.org/10.1007/s10495-010-0489-5; PMID: 20349137
   PubMed Web of Science ®Google Scholar
• Ruan GR, Chen SS, Chang Y, Li JL, Qin YZ, Li LD, et al. [Adenovirus-mediated PDCD5 gene transfer sensitizes apoptosis of K562 cells induced by etoposide]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007; 15:936 - 40; PMID: 17956665
   PubMedGoogle Scholar
• Ruan GR, Zhao HS, Chang Y, Li JL, Qin YZ, Liu YR, et al. Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo. Apoptosis 2008; 13:641 - 8; http://dx.doi.org/10.1007/s10495-008-0206-9; PMID: 18401719
   PubMed Web of Science ®Google Scholar
• Wang Y, Li D, Fan H, Tian L, Zhong Y, Zhang Y. Cellular uptake of exogenous human PDCD5 protein. J Biol Chem 2006; 281:24803 - 17; http://dx.doi.org/10.1074/jbc.M600183200; PMID: 16754680
   PubMed Web of Science ®Google Scholar
• Wang D, Lippard SJ.. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005; 4:307 - 320
   PubMed Web of Science ®Google Scholar
• Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22:7265 - 79; http://dx.doi.org/10.1038/sj.onc.1206933; PMID: 14576837
   PubMed Web of Science ®Google Scholar
• Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25:4798 - 811; http://dx.doi.org/10.1038/sj.onc.1209608; PMID: 16892092
   PubMed Web of Science ®Google Scholar
• Korsmeyer SJ. BCL-2 gene family and the regulation of programmed cell death. Cancer Res 1999; 59:Suppl 1693s - 700s; PMID: 10197582
   PubMed Web of Science ®Google Scholar